One-third of target group now vaccinated against monkeypox 10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox. Science Photo Library / ANP
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Excess mortality decreasing, now also in nursing- and care homes The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers that RIVM publishes daily.
COVID-19 in nursing homes It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.
Excess mortality caused by the novel coronavirus (COVID-19) The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.
Regional differences in the coronavirus epidemic There are significant regional differences in the coronavirus epidemic in the Netherlands.
Interspecies website transferred from RIVM to Utrecht University The Interspecies website which helps researchers to reduce and refine the use of laboratory animals is transferred to the 3Rs database Programme of the 3Rs-Centre Utrecht Life Sciences (ULS) of Utr